Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Pharmacol., 16 November 2018

Sec. Cancer Molecular Targets and Therapeutics

Volume 9 - 2018 | https://doi.org/10.3389/fphar.2018.01248

RETRACTED: AFAP1-AS1 Promotes Epithelial-Mesenchymal Transition and Tumorigenesis Through Wnt/β-Catenin Signaling Pathway in Triple-Negative Breast Cancer

Updated

A retraction of this article was approved in:

  1. Retraction: AFAP1-AS1 promotes epithelial-mesenchymal transition and tumorigenesis through Wnt/β-catenin signaling pathway in triple-negative breast cancer

    1. Read retraction

  2. RETRACTED: Corrigendum: AFAP1-AS1 Promotes Epithelial-Mesenchymal Transition and Tumorigenesis Through Wnt/β-Catenin Signaling Pathway in Triple-Negative Breast Cancer

    1. Read correction
Kaiming Zhang&#x;Kaiming Zhang1†Peng Liu&#x;Peng Liu1†Hailin Tang&#x;Hailin Tang1†Xiaoming XieXiaoming Xie1Yanan KongYanan Kong1Cailu SongCailu Song1Xingsheng Qiu*Xingsheng Qiu2*Xiangsheng Xiao*Xiangsheng Xiao1*
  • 1Department of Breast Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China
  • 2Department of Neurology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China

This article has been retracted. Please follow the link to the full retraction notice for details.

Received: 15 June 2018; Accepted: 12 October 2018;
Published: 16 November 2018; Retracted: 16 January 2026.

Edited by:

Zhi Sheng, Virginia Tech, United States

Reviewed by:

Chun Hei Antonio Cheung, National Cheng Kung University, Taiwan
Shiv K. Gupta, Mayo Clinic, United States

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.